SCHEMBL5255157

SCHEMBL5255157

O=C(NC1CCCCC1C(=O)O)c1ccc2ccccc2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR3 P32745 1/20 0.58
HDAC8 Q9BY41 1/20 0.52
RAB9A P51151 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
NFKB1 P19838 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52
ALDH1A1 P00352 4/20 0.51
GAA P10253 2/20 0.51
MAPT P10636 2/20 0.51
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
KDM4C Q9H3R0 1/20 0.50
HTT P42858 1/20 0.49
MGAM O43451 1/20 0.49
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
MAPK1 P28482 1/20 0.48
TDP1 Q9NUW8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5256700 1.00 SSTR3 (0.58) SSTR3HDAC8RAB9ASMN1; SMN2NFKB1
SCHEMBL14565583 1.00 SSTR3 (0.58) SSTR3HDAC8RAB9ASMN1; SMN2NFKB1
SCHEMBL14565584 0.84 ALDH1A1 (0.53) SSTR3HDAC8RAB9ASMN1; SMN2NFKB1
SCHEMBL5260072 0.83 SMN1; SMN2 (0.53) RAB9ASMN1; SMN2ALDH1A1NPC1HPGD
SCHEMBL28746033 0.83 SMN1; SMN2 (0.53) RAB9ASMN1; SMN2ALDH1A1NPC1HPGD
SCHEMBL5256081 0.83 SMN1; SMN2 (0.53) RAB9ASMN1; SMN2ALDH1A1NPC1HPGD
SCHEMBL5255112 0.82 SSTR3 (0.52) SSTR3ALDH1A1GAAMAPTMEN1
SCHEMBL14565670 0.81 SSTR3 (0.51) SSTR3ALDH1A1GAAMAPTMEN1
SCHEMBL22449386 0.81 HDAC8 (0.58) SSTR3HDAC8RAB9ASMN1; SMN2NFKB1
SCHEMBL3457004 0.81 HDAC8 (0.58) SSTR3HDAC8RAB9ASMN1; SMN2NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453801-B1 SUBSTITUTED 2-AMINO-CYCLOALKANECARBOXAMIDES AND THEIR USE AS CYSTEINE PROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2007-03-21 EP disclosed